| EN
Currency :
Choose your country/region & currency
  • Americas
    1. United States: USD
    2. Canada: USD
    3. Mexico: USD
    4. Brazil: USD
    5. All Others: USD
|
Home>Bulk Products>4-Methyl-8-(3-nitrocyclohexyl)-2,6-dioxohexahydro-[1,3,2]oxazaborolo[2,3-b][1,3,2]oxazaborol-4-ium-8-uide

About Us

Founded in 2014, BLD Pharmatech Ltd. is a leading supplier and manufacturer of research chemicals to pharmaceutical companies, universities, biotech companies,healthcare industries,contract research organizations etc.


With its own R&D center in Shanghai, BLD Pharmatech Ltd. main field of expertise covers the development and production of heterocycles,boronic acids, amino acids, metal catalysts and chiral compounds.

Qualifications

DUNS: 560440352

BD209672[N/A]4-Methyl-8-(3-nitrocyclohexyl)-2,6-dioxohexahydro-[1,3,2]oxazaborolo[2,3-b][1,3,2]oxazaborol-4-ium-8-uide*

Specific Information

Purity : 95+% Specific Rotation :
NMR(H/C/F/S/P) : E.E. :
HPLC : Water Content :
Polymerization Inhibitor : Single Impurity :
Melting Point : Density :
Packaging : Solubility :
Name Note : Acetic Acid :
Beilstein : Grade :
Specific Gravity : Viscosity :
Others :

Product Details

Cat No. : BD209672 Synonyms : 4-Methyl-8-(3-nitrocyclohexyl)-2,6-dioxohexahydro-[1,3,2]oxazaborolo[2,3-b][1,3,2]oxazaborol-4-ium-8-uide
CAS No. : N/A MDL NO : N/A
Formule : C11H17BN2O6 InChI Key : N/A
M.W : 284.07 Pubchem ID :
Boiling Point :

Safety

Signal Word : Danger Class : 6.1
Precautionary Statements : P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501 UN# : 2811
Hazard Statements : H301-H311-H331 Packing Group :
GHS Pictogram:

R&D Center